Repository logo
 
Publication

Shotgun proteomics of red blood cells from obstructive sleep apnea patients under positive airway pressure (PAP) treatment

2022-05Conference object Open access
Simple item page
dc.contributor.authorCoelho, Cristina Valentim
dc.contributor.authorOsório, Hugo
dc.contributor.authorVaz, Fatima
dc.contributor.authorNeves, Sofia
dc.contributor.authorPinto, Paula
dc.contributor.authorBarbara, Cristina
dc.contributor.authorPenque, Deborah
dc.date.accessioned2022-12-02T11:29:12Z
dc.date.available2022-12-02T11:29:12Z
dc.date.issued2022-05
dc.description.abstractObstructive Sleep Apnea (OSA) syndrome is characterized by recurrent episodes of apneas and hypopneas during sleep, leading to recurrent intermittent hypoxia and sleep fragmentation. No treated OSA can result in metabolic and cardiovascular diseases. By 2D gel-based proteomics approach we have demonstrated that OSA can cause alterations in the red blood cells (RBC) proteome that may be associated with OSA outcomes. OSA induces alterations in the redox/oligomeric states of RBC proteins such as gyceraldehyde-3-phosphate dehydrogenase (GAPDH) and peroxiredoxin-2 (PRDX2) that can be reverted or modulated by PAP treatment. In this study, we applied a shotgun proteomics strategy to further investigate the RBC proteome from patients with OSA before and after PAP treatment to better understand the regulation of RBC homeostasis in the context of OSA and/or under effect of PAP treatment. As a first approach, RBCs samples, corresponding to Snorers patients as control (n=23) and patients with OSA before and after six months of PAP treatment (n=33/condition) were selected from our biobank1. Samples were randomly pooled (n=3 per group/condition) and lysed 1:6 with 5mM sodium phosphate buffer containing 100 mM of N-ethylmaleimide, a reagent that alkylates free sulfhydryl groups, before haemoglobin depletion by using HemovoidTM system. Depleted samples were alkylated, reduced and digested with trypsin and chymotrypsin. The resulting peptides were cleaned with C18 columns and analysed in triplicate by a Nano High Performance Liquid Chromatography (nanoHPLC) on-line coupled to a high-resolution accurate-mass Orbitrap mass spectrometer (Q Exactive, Thermo Scientific) with a nano electrospray ionization source (nanoESI). The acquired mass spectrometry data were analysed by MaxQuant v1.5.8.3 and Perseus v2.0.3.1 software. The preliminary results corroborated our previous findings by showing that proteins associated with stress response and antioxidant regulatory system were the most changed in OSA RBC compared with Snorers ones. The active catalytic cysteine (Cys 51) in the PRDX2 was identified trioxidized –SO3H almost exclusively in OSA RBC before PAP treatment. Further analyses and validation of these data are in progress, which will certainly provide a better understanding of RBC molecular mechanisms and their proteins/PTMs associated with OSA pathology and/or response to PAP therapy.pt_PT
dc.description.sponsorshipProject partially supported by the Harvard Medical School-Portugal Program (HMSP-ICJ/0022/2011), the ToxOmics (FCT-UID/BIM/00009/2013) and the Portuguese Mass Spectrometry Network (RNEM). CVC is recipient of FCT doctoral scholarship FCT-SFRH/BD/133511/2017.pt_PT
dc.description.versioninfo:eu-repo/semantics/draftpt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/8369
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.relationCentre for Toxicogenomics and Human Health
dc.relationProteome Profiling in Obstructive Sleep Apnea Severity and Treatment Response Towards Early Diagnosis and Prognosis Prediction
dc.relation.publisherversionhttps://bitok.datastore.pt/scimeet-prod/cms/proteo-vilamoura.sci-meet.net/2ea9f866-0e51-4cfc-9e7c-10ed31aefabb/ProteoVilamoura_BookOfAbstracts_low.pdfpt_PT
dc.subjectObstructive Sleep Apnea (OSA)pt_PT
dc.subjectPeroxiredoxin-2pt_PT
dc.subjectProteomicspt_PT
dc.subjectGenómica Funcionalpt_PT
dc.subjectGenómica Funcional e Estruturalpt_PT
dc.titleShotgun proteomics of red blood cells from obstructive sleep apnea patients under positive airway pressure (PAP) treatmentpt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.awardTitleCentre for Toxicogenomics and Human Health
oaire.awardTitleProteome Profiling in Obstructive Sleep Apnea Severity and Treatment Response Towards Early Diagnosis and Prognosis Prediction
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/HMSP-ICJ%2F0022%2F2011/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FBIM%2F00009%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F133511%2F2017/PT
oaire.citation.conferencePlaceVilamoura, Portugalpt_PT
oaire.citation.titleProteoVilamoura-2nd Joint Meeting of Spanish, French and Portuguese Proteomics Societies, 11-13 May 2022pt_PT
oaire.fundingStream3599-PPCDT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStreamOE
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isProjectOfPublicationa9bad44d-3ec0-4cf1-acdc-ce4155e0f68a
relation.isProjectOfPublicationa803b42a-2bae-48f9-88fc-fe2281aa7075
relation.isProjectOfPublication39802557-af64-4b35-834f-3e015a20919e
relation.isProjectOfPublication.latestForDiscoverya9bad44d-3ec0-4cf1-acdc-ce4155e0f68a

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ProteoVilamoura_BookOfAbstracts_low_I1.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DGH - Posters/abstracts em congressos internacionais